Clovis Oncology Overview

Clovis Oncology Operating Income

Operating Income for CLVS.

Quarterly Operating Income

$-44235000.00

↓ 18.37% YoY

As of Sep 30, 2022

Annual Operating Income (TTM)

$-206685000.00

↓ 11.13% YoY

Trailing 12 months ending Sep 30, 2022

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin